Edition:
United States

Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

145.99USD
16 Nov 2018
Change (% chg)

$1.49 (+1.03%)
Prev Close
$144.50
Open
$144.67
Day's High
$146.72
Day's Low
$144.55
Volume
3,171,391
Avg. Vol
2,019,441
52-wk High
$148.32
52-wk Low
$118.62

Chart for

About

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer... (more)

Overall

Beta: 0.56
Market Cap(Mil.): $388,028.59
Shares Outstanding(Mil.): 2,681.98
Dividend: 0.90
Yield (%): 2.49

Financials

  JNJ.N Industry Sector
P/E (TTM): 26.08 28.12 29.34
EPS (TTM): 5.55 -- --
ROI: 12.01 14.10 13.58
ROE: 21.85 15.67 15.11

New jury fails to reach verdict in J&J South Carolina talc cancer trial

A second South Carolina jury on Thursday failed to reach a verdict in the retrial of a case by a woman whose family said her long-term use of Johnson & Johnson's baby powder led to her death from asbestos-related cancer.

Nov 15 2018

New jury fails to reach verdict in J&J S. Carolina talc cancer trial

Nov 15 A second South Carolina jury on Thursday failed to reach a verdict in the retrial of a case by a woman whose family said her long-term use of Johnson & Johnson's baby powder led to her death from asbestos-related cancer.

Nov 15 2018

Imerys asks MDL judge to block plaintiffs' access to talc tests in state court

The talc supplier to Johnson & Johnson is asking a federal judge in New Jersey to weigh in on a discovery request in a California state court lawsuit alleging asbestos contamination in J&J talc products caused a woman to develop cancer.

Nov 14 2018

Jury clears J&J of liability in California talc cancer case

A California jury on Wednesday cleared Johnson & Johnson of liability in a case involving a woman who alleged that the company's talc-based products, including its baby powder, contain asbestos and caused her cancer, the company said.

Nov 14 2018

Jury clears J&J of liability in California talc cancer case

Nov 14 A California jury on Wednesday cleared Johnson & Johnson of liability in a case involving a woman who alleged that the company's talc-based products, including its baby powder, contain asbestos and caused her cancer, the company said.

Nov 14 2018

Case to Watch: J&J, others face new talc cancer trial against firm that won $4.7 bln in similar case

As trials against Johnson & Johnson and its supplier Imerys Talc America over allegedly asbestos-contaminated talcum powder products causing cancer are ramping up across the country, the law firm that clinched a multi-plaintiff $4.69 billion talc verdict in July is preparing for another jury to hear its arguments.

Nov 13 2018

Kentucky appeals court says suit over J&J heart catheter rightly dismissed

A Kentucky appeals court has affirmed the dismissal of a lawsuit against Johnson & Johnson's Biosense unit over a heart catheter that injured a man during a clinical trial, saying the claims were preempted by federal law.

Nov 12 2018

Case to Watch: J&J faces wave of Risperdal trials in Philadelphia mass tort program

Dozens of men suing Johnson & Johnson over its antipsychotic drug Risperdal are preparing for upcoming trials in Philadelphia state court over claims the medication caused them to develop breasts, with the company facing the prospect of stiff punitive damages in trials scheduled to begin on Dec. 3.

Nov 06 2018

Breakingviews - Private equity could scratch Nestlé skin-care itch

LONDON (Reuters Breakingviews) - Acne and other skin creams have had a spotty record at Nestlé, but a buyout group might do better. A unit at the world’s biggest food group that makes Botox rival Dysport may fetch at least 6 billion Swiss francs ($6 billion). Rival consumer groups may be put off by the business’s products and low margins, but they could appeal to a private equity firm. Facing pressure from activist Dan Loeb, Nestlé Chief Executive Mark Schneider announced a review of the divi

Nov 06 2018

Plaintiffs in talc cancer MDL accuse J&J, Imerys of violating discovery orders

Plaintiffs alleging that Johnson & Johnson and Imerys Talc America's baby powder contains cancer-causing asbestos accused the companies on Wednesday of engaging in "significant" discovery violations by withholding documents and talc samples until the "eleventh hour."

Nov 02 2018

Earnings vs. Estimates